Evonik saw sales rise 2% to €14.4bn and EBIT rises 14% to €1.3bn. The Chemicals business benefited from higher demand, an improvement in selling prices, lower depreciation and the recent restructuring. The company is still looking either to sell shares in an IPO or for a trade sale of a stake.
Evonik
Reuters
Monday 17 March 2008
Good 2007 for Evonik, still looking for sale
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment